IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$773M
AUM Growth
+$278M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1
+$33.1M
2
+$14.6M
3
+$14.3M
4
OLMA icon
Olema Pharmaceuticals
OLMA
+$13.5M
5
LLY icon
Eli Lilly
LLY
+$13.2M

Top Sells

1
+$53M
2
+$20.7M
3
+$16M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.6M
5
PTCT icon
PTC Therapeutics
PTCT
+$11.8M

Sector Composition

1 Healthcare 99.47%
2 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
151
Dyne Therapeutics
DYN
$2.45B
– –
-113,837
GMAB icon
152
Genmab
GMAB
$17.1B
– –
-175,000
GOSS icon
153
Gossamer Bio
GOSS
$117M
– –
0
IFRX icon
154
InflaRx
IFRX
$62.1M
– –
-722,066
JANX icon
155
Janux Therapeutics
JANX
$830M
– –
-54,691
LQDA icon
156
Liquidia Corp
LQDA
$2.92B
– –
0
LRMR icon
157
Larimar Therapeutics
LRMR
$439M
– –
0
MLTX icon
158
MoonLake Immunotherapeutics
MLTX
$1.3B
– –
-435,839
NKTR icon
159
Nektar Therapeutics
NKTR
$2.05B
– –
0
NVO icon
160
Novo Nordisk
NVO
$173B
– –
0
OMER icon
161
Omeros
OMER
$808M
– –
0
PRME icon
162
Prime Medicine
PRME
$731M
– –
-150,000
RLAY icon
163
Relay Therapeutics
RLAY
$1.68B
– –
-467,362
SNDX icon
164
Syndax Pharmaceuticals
SNDX
$1.85B
– –
-333,733
SONN
165
DELISTED
Sonnet BioTherapeutics
SONN
– –
-150,000
SPRY icon
166
ARS Pharmaceuticals
SPRY
$914M
– –
0
SRPT icon
167
Sarepta Therapeutics
SRPT
$1.73B
– –
0
SRRK icon
168
Scholar Rock
SRRK
$4.87B
– –
0
TEVA icon
169
Teva Pharmaceuticals
TEVA
$37.1B
– –
0
TVTX icon
170
Travere Therapeutics
TVTX
$2.55B
– –
-190,781
UTHR icon
171
United Therapeutics
UTHR
$21.2B
– –
0
VRDN icon
172
Viridian Therapeutics
VRDN
$2.88B
– –
-245,518
XBI icon
173
State Street SPDR S&P Biotech ETF
XBI
$8.16B
– –
0
ZYME icon
174
Zymeworks
ZYME
$1.91B
– –
-72,787
ALMS
175
Alumis Inc
ALMS
$3.48B
– –
0
4 5 6
7
8